SEARCH   
MEMBER LOGIN    
Forgot Password?

Generic Pharmaceutical Manufacturing in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Generic Pharmaceutical Manufacturing Market Research Report | NAICS 32541b | Apr 2017

Spoonful of sugar: Healthcare reform and patent expiration will boost industry revenue

IBISWorld’s Generic Pharmaceutical Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Industry Statistics & Market Size
Revenue
$68bn
Annual Growth 12-17
3.2%
Annual Growth 17-22
Annual Growth
Profit
Profit
Employment
79,087
Businesses
1,358
Industry Threats & Opportunities
  • Industry revenue growth has outpaced that of brand name pharmaceuticals due to the patent cliff
  • New industry operators are increasingly focused on producing generic biologic drugs, known as biosimilars
  • Consumer preference for generic drugs will continue to increase
  • ... purchase to read more

Industry Analysis & Industry Trends

The Generic Pharmaceutical Manufacturing industry is expanding rapidly. An aging population with more chronic illnesses is driving demand for industry products, while regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development. Over the past five years, industry revenue growth has outpaced revenue growth for the Brand Name Pharmaceutical Manufacturing industry (IBISWorld report 32541a). Many brand name manufacturers lost patent protection for blockbuster drugs during the period, increasing consumer demand for more affordable generic versions of these high-profile products. These trends will likely continue over the next five years... ... purchase to read more

Industry Report - Starting a New Business Chapter

Brand name drugs have the benefit of barriers to entry in the form of patent protection. Although generic manufacturers lack such a barrier, there are many other barriers to entry such as regulation requirements and consolidation in downstream markets. Pharmaceutical companies, both generic and brand name, have generally maintained high profit levels, indicating that high barriers are keeping new producers from entering to take advantage of relatively easy-to-earn margins. Barriers have been reduced slightly over the past five years, as strong industry growth has provided small companies with more opportunities to be acquired by larger ones.

.. ... purchase to read more

Additional Insights for the Generic Pharmaceutical Manufacturing Industry

IBISWorld identifies 250 Key Success Factors for a business.The most important for the Generic Pharmaceutical Manufacturing Industry are

  • Control of distribution arrangements
  • Degree of globalization
  • Undertaking generic pharmaceutical and medicine research and development
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Number of people with private health insurance in the Generic Pharmaceutical Manufacturing industry impact industry performance... purchase to read more

     


    Industry ProductsRelated Reports

    What is the Generic Pharmaceutical Manufacturing Industry?

    Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

    Industry Products
    Mental health and lipid regulators Antidiabetics and respiratory Pain and antibacterials Nervous system disorders and antihypertensives Antiulcerants and thyroid Dermatologicals and hormonal contraceptives ADHD and anticoagulants
     
    Industry Activities
    Developing and producing generic drugsMarketing and distributing generic drugsGaining regulatory approval for generic drugs


    Table of Contents
    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Number of people with private health insurance
  • Research and development expenditure
  • Median age of population
  • Trade-weighted index
  • Current Performance
  • Brand name and generic
  • New opportunities
  • Chart: Revenue Growth
  • Industry Outlook
  • Research and development
  • The regulatory environment
  • Industry landscape
  • Table: Generic Pharmaceutical Manufacturing Industry Revenue Outlook
  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Generic Pharmaceutical Manufacturing Industry Lifecycle vs The Economy
  • Products & Markets
    Supply Chains
  • Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Hospitals
  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Navigational Instrument Manufacturing
  • Soap & Cleaning Compound Manufacturing
  • Products & Services
  • Nervous system disorders and antihypertensives
  • Other
  • Mental health and lipid regulators
  • Pain and antibacterials
  • Antidiabetics and respiratory
  • Antiulcerants and thyroid
  • Dermatologicals and hormonal contraceptives
  • ADHD and anticoagulants
  • Chart: Generic Pharmaceutical Manufacturing Industry Products and Services Segmentation
  • Demand Determinants
    Major Markets
  • Third-party payers
  • Medicare
  • Medicaid
  • Out-of-pocket
  • Chart: Major Market Segmentation for the Generic Pharmaceutical Manufacturing Industry
  • International Trade
    Business Locations
  • Chart: Business Locations by State
  • Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Chart: Cost Structure Benchmarking – Sector vs Generic Pharmaceutical Manufacturing
  • Basis of Competition
    Barriers to Entry
  • Table: Barrier to Entry Checklist for the Generic Pharmaceutical Manufacturing Industry
  • Industry Globalization
    Major Companies
    Mylan Inc.
    Teva Pharmaceutical Industries Ltd.
    Sandoz Ltd.
  • Table: Mylan Inc. - financial performance
  • Table: Teva Pharmaceutical Industries Ltd. - financial performance
  • Table: Sandoz Ltd. - financial performance
  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Generic Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success
  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth
  • Regulation & Policy
    Industry Assistance
    Key Statistics
  • Table: Industry Data for the Generic Pharmaceutical Manufacturing Industry
  • Includes:
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Total health expenditure (2008-2022)
  • Table: Annual Percentage Change for Key Industry Data
  • Table: Key Ratios for Industry Key Data
  • Table: Industry Financial Ratios
  • Jargon & Glossary
    Abbreviated New Drug Application (Anda)
  • An application for the approval of a generic drug where manufacturers must scientifically prove that their products are bioequivalent to the brand products.
  • Authorized Generic
  • A prescription drug produced by brand pharmaceutical companies and marketed under a private label at a generic product price.
  • Biopharmaceuticals
  • A large protein molecule derived from living sources, as opposed to a chemical substance. Examples include insulin, human growth hormones and antibiotics.
  • Biosimilar
  • Versions of innovator biopharmaceutical products that follow patent and exclusivity expirations on innovator products.
  • Doughnut Hole
  • The Medicare Part D coverage gap; the difference of the initial coverage limit and the catastrophic coverage threshold.
  • Evergreening
  • The process whereby pharmaceutical companies slightly tweak the formulation of their high-profile products to avoid patent expiration.
  • New Drug Application (Nda)
  • An application filed for the approval of a new drug product. Once approved, the product may be marketed in the United States.
  • Patent Cliff
  • A phenomenon wherein revenue for brand name pharmaceuticals drop as the patents for high-profile drugs expire.

  • Why Buy this Report?
    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Generic Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Generic Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Generic Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    View Sample
    Quote
    Select Clients
    Back to Top